Obstructive Sleep Apnea Obstructive sleep apnea (OSA) is characterized by recurrent partial or complete upper airway obstruction during sleep, leading to intermittent hypoxia and sleep fragmentation.[44] Obesity is a major risk factor for OSA, prompting investigation into whether GLP-1RAs could serve as a therapeutic option.[44] Clinical studies have shown that liraglutide reduces the apnea-hypopnea index (AHI) in patients with OSA
ProHealth suits those preferring self-directed supplementation without prescription requirements
Your provider may order tests such as: Fasting glucose Fasting insulin or HOMA-IR (to assess insulin resistance) Hemoglobin A1C (for long-term blood sugar control) Lipid panel (cholesterol and triglycerides) Liver enzymes This step ensures that your baseline metabolic status is well understood and that any improvements after starting a GLP-1 can be accurately attributed to the new medication, rather than to changes in thyroid therapy
In fact, they're undefeated
Throughout the entire study, the cells in culture tested negative for mycoplasma contamination
In a market where the FDA issued warning letters to more than 30 telehealth companies in early 2026 for GLP-1 marketing violations, LegitScript certification status is the most reliable independent signal of platform compliance available to patients
